Skip to content
10-K

Annual Report

MEDIFAST INC MED

0001628280-25-006094

← back to feed
Filed
Feb 18, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 11, 2025 10.94M sh
Short Term Investments FY 2024 · Dec 31, 2023 $55.6M
Cash And Equivalents FY 2024 · Dec 31, 2023 $94.44M
Current Liabilities FY 2024 · Dec 31, 2023 $92.3M
Total Liabilities FY 2024 · Dec 31, 2023 $108.43M
Current Assets FY 2024 · Dec 31, 2023 $224.03M
Total Assets FY 2024 · Dec 31, 2023 $309.91M
Shares Diluted FY 2024 · Dec 31, 2022 11.28M sh
Stock Repurchased FY 2024 · Dec 31, 2022 $126.45M
Dividends Paid FY 2024 · Dec 31, 2022 $71.62M
Capex FY 2024 · Dec 31, 2022 $16.68M
Operating Cash Flow FY 2024 · Dec 31, 2022 $194.57M
Eps Diluted FY 2024 · Dec 31, 2022 $12.73
Eps Basic FY 2024 · Dec 31, 2022 $12.82
Sga Expense FY 2024 · Dec 31, 2022 $955.61M
Rd Expense FY 2024 · Dec 31, 2022 $4.5M
Net Income FY 2024 · Dec 31, 2022 $143.57M
Operating Income FY 2024 · Dec 31, 2022 $184.81M
Gross Profit FY 2024 · Dec 31, 2022 $1.14B
Cost Of Revenue FY 2024 · Dec 31, 2022 $458.16M
Revenue FY 2024 · Dec 31, 2022 $1.6B
Stockholders Equity FY 2024 · Dec 31, 2021 $202.47M